Abstract
Objective: We aimed to compare the platelet mass index (PMI) which is one of the indices not previously evaluated for prediction of preeclampsia patients with using other platelet indices in the healthy control group, in preeclampsia and in gestational hypertension patients. 
 Method: This retrospective study was conducted by scanning the files of patients hospitalized between January 1, 2016 and January 1, 2020 in Mersin University Gynecology and Obstetrics clinics; 88 gestational hypertension, 210 preeclampsia and 140 healthy control patients were selected according to the study criteria. Platelet count (PC) and mean platelet volume (MPV) values were recorded from patients’ folder. Platelet mass index was calculated by the formula platelet count x mean platelet volume/103. 
 Results: As a result of the laboratory findings, PC, PMI and PC/MPV values differ between the groups. When the subgroups were studied, there was no difference between the GHT group and the control group. PC, PMI and PC/MPV mean values of the PE group were significantly lower than the control group (p=0.016, p=0.023, p=0.026 respectively). Sensitivity and specificity of PMI was found to be 53.6% and 52.6% respectively for the prediction of the preeclampsia, when the cut-off value of PMI is taken as 2303.35 ml/103 (p= 0.021).
 Conclusion: It was found that PC, PC/MPV and firstly evaluated PMI decreased statistically significant in patients with preeclampsia.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
